NCT07542158 2026-04-21
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
Phase 2 Enrolling by invitation
Clinical Trials
11 trialsNCT05212272 2026-03-23
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
Wake Forest University Health Sciences
Phase NA Recruiting
NCT06575452 2025-12-03
EPIGLIO
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Not yet recruiting
NCT06942104 2025-07-18
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
Phase 1 Recruiting
NCT05133154 2025-07-11
GLIOLIPSY
University Hospital, Montpellier
Phase NA Recruiting
NCT04025541 2025-04-02
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT06116903 2024-12-13
ExoGLIE
University Hospital, Limoges
Phase NA Recruiting
NCT01674582 2020-09-03
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Phase NA Completed
NCT04051047 2019-11-27
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT02041611 2018-06-27
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00897611 2012-11-30
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed